Electrocore, inc.ECOR.US Overview

US StockHealthcare

(No presentation for ECOR)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

ECOR Overall Performance

ECOR AI Analysis & Strategy

ECOR Recent Performance

0.12%

Electrocore, inc.

0.81%

Avg of Sector

-1.14%

S&P500

ECOR PowerScanner

ECOR Key Information

ECOR Valuation Metrics

ECOR Earnings Table

ECOR Profile

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.